Dr. Pestell founded ProstaGene to rapidly bring to cancer patients the benefits of the prostate cancer testing and metastasis technologies discovered under his leadership at the Sidney Kimmel Cancer Center. He is the inventor of record in the ProstaGene patents. He is leading ProstaGene as an active Board Chair, is directly engaged in the recruitment of a fulltime CEO and a Senior Licensing Executive, and will continue to provide Board Chair leadership in the future.
- Professor of Finance, Stern School of Business, New York University.
- President and Chief Operating Officer of PREIT since 2004-2012.
- Executive Vice President and Chief Financial Officer of PREIT from 1997 to 2004.
Mr. Glickman began his professional career as an investment banker in New York City before joining The Rubin Organization as its chief financial officer. The Rubin Organization was acquired by PREIT in 1997. He initially served PREIT as its Chief Financial Officer before becoming its President and Chief Operating Officer in 2004 and a member of its Office of the Chair.
Mr. Glickman brings to the Board of Trustees, among other skills, a deep understanding of public and private capital markets, the day-to-day operations and personnel of PREIT and economic conditions and developments that directly or indirectly affect the business and strategic direction of PREIT.